NanoVibronix Announces Closing of $3.4 Million Bought Deal Offering and Partial Exercise of Underwriter's Option to Purchase Additional SharesPRNewsWire • 08/27/20
NanoVibronix Receives Reimbursement Approval from U.S. Centers for Medicare & Medicaid Services (CMS) for PainShield™GlobeNewsWire • 04/01/20
NanoVibronix looks to expand use of its UroShield Due to the potential to impact comorbidities related to COVID-19 CrisisGlobeNewsWire • 03/27/20